Storage Trends for 2018: Cloud Storage 2.0 Players Poised to Ascend
David Friend of Wasabi shares his prediction for the cloud storage market. Read more >>
03
Jan
Related Posts
20
Jun
Blind Guilford Teen Can Now See Thanks to High-Tech Pair of Glasses
Blind Guilford Teen Can Now See Thanks to High-Tech Pair of Glasses. Read more >>
read more
21
Jan
KnipBio moves towards commercial production of single cell protein
The producer of premium aquaculture feed Ingredients KnipBio, Inc. announced they successfully completed the production process of KnipBio Meal™…
read more
30
Sep
Siamab Therapeutics Presented New Data for its Anti-STn Antibody Therapeutics Showing Myeloid-Derived Suppressor Cells as a Promising Cancer Immunotherapy Target at Cambridge Healthtech Institute’s Targeting Tumor Myeloid Cells Conference
Siamab Therapeutics, Inc., a biopharmaceutical company developing novel cancer immunotherapies, today announced it presented new preclinical data for its…
read more
29
Apr
District Ventures Capital Invests in Premama Wellness
District Ventures Capital (“District Ventures”) announced today it has closed an equity investment with Premama Wellness (“Premama”), producers of…
read more
31
May
eSight Corp. Announces a new CEO and $10 Million in Funding
eSight, the leading vision-platform organization behind the world’s most advanced sight-enhancing glasses for the visually impaired, is pleased to…
read more
15
Sep
Save your frustrations and fabrics with DetraPel
DetraPel aims for us to wear and love our belongings longer by protecting fabrics against liquid damage such as…
read more
27
Nov
Markham girl regains her vision with eSight glasses
A fourth-grade student from Markham with a condition that highly compromises her vision has regained her sight thanks to…
read more
16
Oct
5 minutes with … David Friend, CEO of Wasabi
The seventh company serial entrepreneur David Friend founded across his 40-year career, Wasabi Technologies Inc., just scored what he…
read more
08
Aug
Corbus Pharmaceuticals to Present New Data from Systemic Sclerosis Phase 2 Study of Anabasum at the 15th International Workshop on Scleroderma Research
Corbus Pharmaceuticals Holdings, Inc.(NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical stage drug development company targeting rare, chronic, serious…
read more
23
Nov
Myomo Wants to Help Brain Injury Survivors Overcome Paralysis
For those who experience a stroke or traumatic brain injury, some are left with having to cope and adapt…
read more